Searched for
SYSTEMIC ORAL STEROIDS
Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Dr. Abigail Waldman’s Dermatologist-Approved Guide To Fading Dark SpotsHyperpigmentation, a common skin issue, needs patience and the right ingredients for results. Doctor Abigail Waldman suggests combining tre...
- Delhi air is destroying your child’s lungs: From chronic coughs to emergency surgeries, doctors reveal shocking casesDoctors in Delhi-NCR are alarmed by the severe impact of air pollution on children, leading to chronic respiratory ailments like bronchitis...
- Zydus Lifesciences gets USFDA nod for Deflazacort oral suspensionZydus Lifesciences Ltd received final USFDA approval for its generic Deflazacort oral suspension (22.75 mg/ml) on Monday. This medication t...
- Sneezing and coughing despite hot weather? Doctor reveals the cause as 5–7 patients visit daily with this issueHospitals are witnessing a surge in allergy cases, with patients experiencing sneezing, runny noses, and itchy eyes. Doctors attribute thes...
- A commonly used arthritis medicine can cure baldness, shows a studyA recent study published in Indian Dermatology has found that tofacitinib, a drug commonly used for rheumatoid arthritis, has shown promisi...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
- How Laurus Labs capex drive can impact its margins & valuationsRise in headwinds in the pharma industry due to inflation, increase in raw material costs, and excessive competition led to price erosion i...
- Skin complications post vaccination reported in some people, say dermatologistsWhile fever, body ache and weakness are common reactions in response to vaccination, doctors said a few people, after getting the jabs, hav...
- Many states recording higher peak of COVID cases than Sept cause of concern: GovtAt a press conference, Joint Secretary in the Health Ministry Lav Agarwal said the country witnessed its first peak in September and is wit...
- Health Ministry warns against 'misplaced bravery', says 'we may be tired but virus isn't'"We are observing misplaced bravery that corona is nothing, its a scam, we have had enough of coronavirus, I don't need a mask, let's party...
- Health Ministry releases revised guidelines for home isolation of mild COVID-19 casesElderly patients aged more than 60 years and those with co-morbid conditions such as hypertension, diabetes, heart disease, chronic lung or...
- View: Why vaccines alone would not be enough to beat Covid-19Vaccines can’t change the course of the pandemic overnight, and may not be able to entirely stop the spread of the virus. It will take mont...
- 'Steroid that costs less than Rs 200 may help prevent Covid-19 deaths'Recovery Trial in the UK found that the steroid dexamethasone reduces deaths by one-third in patients hospitalised with severe respiratory ...
- First drug proves able to improve survival from COVID-19The drug was given either orally or through an IV. After 28 days, it had reduced deaths by 35% in patients who needed treatment with breath...
- World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
Load More
